Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Non-small cell lung cancer in countries of Central and Southeastern Europe : diagnostic procedures and treatment reimbursement surveyed by the Central European Cooperative Oncology Group
Avtorji:Ryška, Ales (Avtor)
Buiga, Rares (Avtor)
Fakirova, Albena (Avtor)
Kern, Izidor (Avtor)
Olszewski, Włodzimierz (Avtor)
Plank, Lukas (Avtor)
Seiwerth, Sven (Avtor)
Toth, Erika (Avtor)
Zivka, Eri (Avtor)
Thallinger, Christiane (Avtor)
Zielinski, Christoph (Avtor)
Brčić, Luka (Avtor)
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:This article analyzes the availability of different diagnostic procedures of non-small cell lung cancer (NSCLC) and the reimbursement landscape of drugs for NSCLC in countries of central and southeastern Europe (CEE). A survey was conducted by the Central European Cooperative Oncology Group. Results of the survey show that both availability and reimbursement of diagnoses of molecular alterations in NSCLC, the detection of which is essential for therapeutic decisions, varies widely between countries of CEE. Not only is "reflex" testing often substituted by analyses performed only "on demand," but reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. It was concluded that a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. Implications for Practice. This article provides an overview of the limitations in lung cancer treatment in countries of central and southeastern Europe, as well as the reimbursement status of various lung cancer treatment regimens in these countries, which directly impacts treatment options.
Ključne besede:Non-small cell lung carcinoma -- diagnosis -- economics -- Europe, molecular diagnostic techniques, precision medicine, Central Europe, Southeastern Europe, reimbursement
Leto izida:2018
Založnik:AlphaMed Press
Izvor:ZDA
UDK:616-006
ISSN pri članku:1549-490X
OceCobissID:521539609 Povezava se odpre v novem oknu
COBISS_ID:2048460913 Povezava se odpre v novem oknu
DOI:10.1634/theoncologist.2018-0008 Povezava se odpre v novem oknu
Opombe:Soavtor iz Slovenije: Izidor Kern; Nasl. z nasl. zaslona; Opis vira z dne 27. 3. 2019;
Število ogledov:780
Število prenosov:171
Datoteke:URL URL - Izvorni URL, za dostop obiščite http://theoncologist.alphamedpress.org/content/23/12/e152
 
Nadgradivo:Oncologist
AlphaMed Press
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
Avtorske pravice:©AlphaMed Press 2018
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Nazaj